These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 32884571)
1. Prognostic Values for the mRNA Expression of the ADAMTS Family of Genes in Gastric Cancer. Liang L; Zhu JH; Chen G; Qin XG; Chen JQ J Oncol; 2020; 2020():9431560. PubMed ID: 32884571 [TBL] [Abstract][Full Text] [Related]
2. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis. Zhu YZ; Liu Y; Liao XW; Luo SS Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708 [TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic significance of thrombospondin gene family in gastric cancer. Deng LY; Zeng XF; Tang D; Deng W; Liu HF; Xie YK J Gastrointest Oncol; 2021 Apr; 12(2):355-364. PubMed ID: 34012631 [TBL] [Abstract][Full Text] [Related]
4. Expression and Prognostic Analysis of Integrins in Gastric Cancer. Wang JF; Wang Y; Zhang SW; Chen YY; Qiu Y; Duan SY; Li BP; Chen JQ J Oncol; 2020; 2020():8862228. PubMed ID: 33335550 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of Aberrantly Expressed Protein-coding Gene Associated With Gastric Cancer's Regulatory T Cells, Based on Online Databases. Zhang Z; Shao X; Wu H; Su X; Wang G; Zhu L; Ji Z Altern Ther Health Med; 2023 Apr; 29(3):160-165. PubMed ID: 36735714 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk between prognostic long noncoding RNAs and messenger RNAs as transcriptional hallmarks in gastric cancer. Zhang J; Yuan Y; Wei Z; Ren J; Hou X; Yang D; Cai S; Chen C; Tan M; Chen GG; Wu K; He Y Epigenomics; 2018 Apr; 10(4):433-443. PubMed ID: 29402138 [TBL] [Abstract][Full Text] [Related]
7. [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics]. Li X; He J; Yu M; Zhang W; Sun J Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):683-692. PubMed ID: 32897212 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of FNDC1 in Gastric Cancer and its Prognostic Significance. Ren J; Niu G; Wang X; Song T; Hu Z; Ke C J Cancer; 2018; 9(24):4586-4595. PubMed ID: 30588242 [No Abstract] [Full Text] [Related]
9. A panel of collagen genes are associated with prognosis of patients with gastric cancer and regulated by microRNA-29c-3p: an integrated bioinformatics analysis and experimental validation. Zhang QN; Zhu HL; Xia MT; Liao J; Huang XT; Xiao JW; Yuan C Cancer Manag Res; 2019; 11():4757-4772. PubMed ID: 31213898 [No Abstract] [Full Text] [Related]
10. Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer. Liu X; Hu C Mol Ther Methods Clin Dev; 2020 Sep; 18():824-838. PubMed ID: 32953933 [TBL] [Abstract][Full Text] [Related]
11. Identification of potential key genes in gastric cancer using bioinformatics analysis. Wang W; He Y; Zhao Q; Zhao X; Li Z Biomed Rep; 2020 Apr; 12(4):178-192. PubMed ID: 32190306 [TBL] [Abstract][Full Text] [Related]
12. Overexpressing PLOD family genes predict poor prognosis in gastric cancer. Li SS; Lian YF; Huang YL; Huang YH; Xiao J J Cancer; 2020; 11(1):121-131. PubMed ID: 31892979 [TBL] [Abstract][Full Text] [Related]
13. [Diverse Functions of a Disintegrin and Metalloproteinase with Thrombospondin Motif-1]. Hirohata S; Inagaki J; Ohtsuki T Yakugaku Zasshi; 2017; 137(7):811-814. PubMed ID: 28674292 [TBL] [Abstract][Full Text] [Related]
14. Identification of HnRNP Family as Prognostic Biomarkers in Five Major Types of Gastrointestinal Cancer. Chen X; Gong R; Wang J; Ma B; Lei K; Ren H; Wang J; Zhao C; Wang L; Yu Q Curr Gene Ther; 2022; 22(5):449-461. PubMed ID: 35794744 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of CLIC3 mRNA overexpression in bladder cancer. Chen M; Zhang S; Wen X; Cao H; Gao Y PeerJ; 2020; 8():e8348. PubMed ID: 31934512 [TBL] [Abstract][Full Text] [Related]
16. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer. Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489 [TBL] [Abstract][Full Text] [Related]
17. Molecular dysexpression in gastric cancer revealed by integrated analysis of transcriptome data. Li X; Dong W; Qu X; Zhao H; Wang S; Hao Y; Li Q; Zhu J; Ye M; Xiao W Oncol Lett; 2017 May; 13(5):3177-3185. PubMed ID: 28521423 [TBL] [Abstract][Full Text] [Related]
18. Analysis the prognostic values of solute carrier (SLC) family 39 genes in gastric cancer. Ding B; Lou W; Xu L; Li R; Fan W Am J Transl Res; 2019; 11(1):486-498. PubMed ID: 30788004 [TBL] [Abstract][Full Text] [Related]
19. Semaphorin4F is a potential biomarker for clinical progression and prognosis in gastric cancer. Wang H; Ji X; Chen L; Ju L; Ma Q; Wu Y; Cai W Int J Clin Exp Pathol; 2023; 16(9):210-224. PubMed ID: 37818383 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of Aberrantly Expressed ceRNA network in gastric cancer with and without Chu A; Liu J; Yuan Y; Gong Y J Cancer; 2019; 10(4):853-863. PubMed ID: 30854091 [No Abstract] [Full Text] [Related] [Next] [New Search]